{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:19:03Z","timestamp":1782296343932,"version":"3.54.5"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1097\/phm.0000000000000382","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T13:33:47Z","timestamp":1442064827000},"page":"330-338","source":"Crossref","is-referenced-by-count":28,"title":["Symptom-Based Treatment of Neuropathic Pain in Spinal Cord-Injured Patients"],"prefix":"10.1097","volume":"95","author":[{"given":"Kyunghoon","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoongul","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Seok","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.sc.3101824","article-title":"A proposed algorithm for the management of pain following spinal cord injury","volume":"44","author":"Siddall","year":"2006","journal-title":"Spinal Cord"},{"key":"R2-2-20210202","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00019053-200927020-00002","article-title":"Neuropathic pain: Quality-of-life impact, costs and cost effectiveness of therapy","volume":"27","author":"O\u2019Connor","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"R3-2-20210202","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.04.007","article-title":"Treatment of neuropathic pain: An overview of recent guidelines","volume":"122","author":"O\u2019Connor","year":"2009","journal-title":"Am J Med"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pain.2009.06.001","article-title":"A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms","volume":"146","author":"Baron","year":"2009","journal-title":"Pain"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1185\/030079906X132488","article-title":"painDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1212\/01.wnl.0000244422.45278.ff","article-title":"Pregabalin in central neuropathic pain associated with spinal cord injury: A placebo-controlled trial","volume":"67","author":"Siddall","year":"2006","journal-title":"Neurology"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1073\/pnas.0708930105","article-title":"Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin","volume":"105","author":"Hendrich","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1523\/JNEUROSCI.0356-09.2009","article-title":"The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin","volume":"29","author":"Bauer","year":"2009","journal-title":"J Neurosci"},{"key":"R9-2-20210202","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/sj.bjp.0706109","article-title":"Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse","volume":"144","author":"Tanabe","year":"2005","journal-title":"Br J Pharmacol"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1471-4159.2008.05212.x","article-title":"Gabapentin produces PKA-dependent pre-synaptic inhibition of GABAergic synaptic transmission in LC neurons following partial nerve injury in mice","volume":"105","author":"Takasu","year":"2008","journal-title":"J Neurochem"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.pmrj.2009.07.002","article-title":"Pain after spinal cord injury: A review of classification, treatment approaches, and treatment assessment","volume":"1","author":"Cardenas","year":"2009","journal-title":"PM R"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0885-3924(03)00067-8","article-title":"Rationale and evidence for the use of oxcarbazepine in neuropathic pain","volume":"25","author":"Carrazana","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"R13-2-20210202","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002508-200201000-00004","article-title":"Pharmacotherapy of trigeminal neuralgia","volume":"18","author":"Sindrup","year":"2002","journal-title":"Clin J Pain"},{"key":"R14-2-20210202","first-page":"CD007963","article-title":"Oxcarbazepine for neuropathic pain","volume":"3","author":"Zhou","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R15-2-20210202","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1179\/204577211X13207446293695","article-title":"International standards for neurological classification of spinal cord injury (revised 2011)","volume":"34","author":"Kirshblum","year":"2011","journal-title":"J Spinal Cord Med"},{"key":"R16-2-20210202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3959(00)00482-6","article-title":"The LANSS Pain Scale: The Leeds assessment of neuropathic symptoms and signs","volume":"92","author":"Bennett","year":"2001","journal-title":"Pain"},{"key":"R17-2-20210202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(83)90088-X","article-title":"Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale","volume":"16","author":"Carlsson","year":"1983","journal-title":"Pain"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/187152412803760645","article-title":"Elucidation of pathophysiology and treatment of neuropathic pain","volume":"12","author":"Vranken","year":"2012","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain: Aetiology, symptoms, mechanisms, and management","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"key":"R20-2-20210202","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol"},{"key":"R21-2-20210202","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.nrl.0000155180.60057.8e","article-title":"Chronic neuropathic pain. Mechanisms, diagnosis, and treatment","volume":"11","author":"Harden","year":"2005","journal-title":"Neurologist"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/s0304-3959(03)00006-x","article-title":"Translation of symptoms and signs into mechanisms in neuropathic pain","volume":"102","author":"Jensen","year":"2003","journal-title":"Pain"},{"key":"R23-2-20210202","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0304-3959(97)00104-8","article-title":"Lamotrigine (lamictal) in refractory trigeminal neuralgia: Results from a double-blind placebo controlled crossover trial","volume":"73","author":"Zakrzewska","year":"1997","journal-title":"Pain"},{"key":"R24-2-20210202","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40263-012-0023-0","article-title":"Refractory trigeminal neuralgia. Non-surgical treatment options","volume":"27","author":"Cruccu","year":"2013","journal-title":"CNS Drugs"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3959(99)00241-9","article-title":"Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia","volume":"85","author":"Vanegas","year":"2000","journal-title":"Pain"},{"key":"R26-2-20210202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000007979","article-title":"Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: A pilot study","volume":"40","author":"Attal","year":"1998","journal-title":"Eur Neurol"},{"key":"R27-2-20210202","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1098-7339(06)80010-6","article-title":"Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat","volume":"22","author":"Hwang","year":"1997","journal-title":"Reg Anesth"},{"key":"R28-2-20210202","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1570159X1201140117162802","article-title":"Pregabalin in neuropathic pain: Evidences and possible mechanisms","volume":"12","author":"Verma","year":"2014","journal-title":"Curr Neuropharmacol"},{"key":"R29-2-20210202","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0959-4388(03)00074-6","article-title":"The role of voltage-gated sodium channels in neuropathic pain","volume":"13","author":"Lai","year":"2003","journal-title":"Curr Opin Neurobiol"},{"key":"R30-2-20210202","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuroscience.2009.08.037","article-title":"Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia","volume":"164","author":"Siqueira","year":"2009","journal-title":"Neuroscience"},{"key":"R31-2-20210202","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2006.01.018","article-title":"Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat","volume":"399","author":"Ultenius","year":"2006","journal-title":"Neurosci Lett"},{"key":"R32-2-20210202","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/brain\/awn169","article-title":"Residual spinothalamic tract pathways predict development of central pain after spinal cord injury","volume":"131","author":"Wasner","year":"2008","journal-title":"Brain"},{"key":"R33-2-20210202","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1523\/JNEUROSCI.0300-04.2004","article-title":"Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury","volume":"24","author":"Hains","year":"2004","journal-title":"J Neurosci"},{"key":"R34-2-20210202","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0079-6123(06)61013-3","article-title":"Sodium channel expression and the molecular pathophysiology of pain after SCI","volume":"161","author":"Hains","year":"2007","journal-title":"Prog Brain Res"},{"key":"R35-2-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.rehab.2008.12.012","article-title":"Neuropathic pain in spinal cord injury: Identification, classification, evaluation","volume":"52","author":"Calmels","year":"2009","journal-title":"Ann Phys Rehabil Med"},{"key":"R36-2-20210202","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainresrev.2008.12.010","article-title":"Mechanisms of chronic central neuropathic pain after spinal cord injury","volume":"60","author":"Hulsebosch","year":"2009","journal-title":"Brain Res Rev"},{"key":"R37-2-20210202","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1351-5101.2003.00725.x","article-title":"Spinal cord injury pain\u2014Mechanisms and treatment","volume":"11","author":"Finnerup","year":"2004","journal-title":"Eur J Neurol"}],"container-title":["American Journal of Physical Medicine &amp; Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PHM.0000000000000382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:59:16Z","timestamp":1620968356000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002060-201605000-00002"}},"subtitle":["A Randomized Crossover Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/phm.0000000000000382","relation":{},"ISSN":["0894-9115"],"issn-type":[{"value":"0894-9115","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}